Comparing Opdivo vs Sylatron
Opdivo | Sylatron |
|
---|
Opdivo (nivolumab) | Sylatron (peginterferon alfa-2b) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Opdivo is an immune checkpoint inhibitor that may be used to treat many different cancers including melanoma, bladder cancer, liver cancer, and lung cancer. Fatigue, skin conditions, a cough, upper... View more |
Prescription only
Prescribed for Melanoma - Metastatic, Melanoma. Sylatron may also be used for purposes not listed in this medication guide. |
Related suggestions Melanoma
Popular comparisons
|
|||||||
More about Opdivo (nivolumab) | More about Sylatron (peginterferon alfa-2b) | ||||||||
Ratings & Reviews | |||||||||
Opdivo has an average rating of 5.3 out of 10 from a total of 87 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 47% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Opdivo side effects in more detail. |
See also: Sylatron side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Opdivo prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
Other peginterferon alfa-2b brands include: PegIntron | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
640.8 hours |
60 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 16 drugs are known to interact with Opdivo:
|
A total of 206 drugs are known to interact with Sylatron:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
|
|||||||||
First Approval Date | |||||||||
December 22, 2014 |
January 19, 2001 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.